Eurosurveillance anniversary scientific seminar
20 years 1996-2016
Eurosurveillance and ProMED, the Program for Monitoring Emerging Diseases, were both created during the mid-90s and have since then facilitated rapid communication about communicable diseases to a broad audience. On the occasion of the 20th Eurosurveillance anniversary, we take a look at how they operate to make this happen.
The fifth Eurosurveillance scientific seminar will take place on 30 November 2016 on the margins of the European Scientific
Conference on Applied Infectious Disease Epidemiology (ESCAIDE).
The programme, a short introduction of the speakers and their presentations are
Dr. Larry Madoff, Director of ProMED, on "Rapid reporting of emerging disease outbreaks using unofficial sources: Lessons from ProMED"
Dr. Madoff is an infectious disease physician specializing in the epidemiology of emerging pathogens, bacterial pathogenesis, and international health. He is Professor of Medicine at the University of Massachusetts Medical School and Lecturer on Medicine at Harvard Medical School. Dr. Madoff serves as Director of the Division of Epidemiology and Immunization and Deputy State Epidemiologist for the Massachusetts Department of Public Health. He aslo has directed ProMED, the Program for Monitoring Emerging Diseases, since 2002.
Dr. Madoff is a member of the American Society for Microbiology, the International Society for Infectious Diseases, past President of the U.S. Lancefield Streptococcal Research Society, a Fellow of the Infectious Diseases Society of America and a Fellow of the American College of Physicians.
Dr. Madoff graduated from Yale College and Tufts Medical School, performed his Internal Medicine Residency at New York Hospital-Cornell Medical Center and his Infectious Disease Fellowship at the Harvard Medical School-Longwood program.
Dr. David Heymann, Associate editor for Eurosurveillance, currently Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine, head of the Centre on Global Health Security at Chatham House, London; and Chairman of Public Health England, UK.
Previously he was the World Health Organization's assistant Director-General for Health Security and Environment, and representative of the Director-General for polio eradication.
From 1998 to 2003, he was the Executive Director of the WHO Communicable Diseases Cluster, during which he headed the global response to SARS. Prior to that, he was the Director for the WHO programme on Emerging and other Communicable Diseases.
Before joining WHO he worked for 13 years as a medical epidemiologist in sub-Saharan Africa, on assignment from the US Centers for Disease Control and Prevention (CDC), where he participated in the first and second outbreaks of Ebola hemorrhagic fever, and supported ministries of health in research aimed at better control of malaria, measles, tuberculosis and other infectious diseases.
Prior to joining CDC he worked in India for two years as a medical epidemiologist in the WHO smallpox eradication programme. He is an elected fellow of the Institute of Medicine of the National Academies (US) and the Academy of Medical Sciences (UK), and has been awarded several public health awards that have provided funding for the establishment of an on-going mentorship programme at the International Association of Public Health Institutes (IANPHI). In 2009 he was appointed an honorary Commander of the Most Excellent Order of the British Empire (CBE) for service to global public health.
On 8 November 2011 Eurosurveillance organised a scientific seminar with three specially invited speakers to celebrate its 15-year anniversary. The seminar took place on the margins of the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) at the same venue. The programme, a short introduction of the speakers and their presentations are
Professor Angus Nicoll moderated the seminar.
Angus Nicoll, Influenza Coordinator at the European Centre for Disease Prevention
and Control, Honorary Professor at the London School of Hygiene and Tropical Medicine.
Dually trained in paediatrics and public health in the United Kingdom. Following
clinical practice lived and worked in Africa 1987-91 on HIV and sexually transmitted
infections establishing the Mwanza Programme. From 1991 to 2005 worked with the
UK Public Health Laboratory Service which became the Health Protection Agency(HPA).
Guided its HIV Unlinked Anonymous Surveillance, became Head of its HIV & STD Division
and then Director of the Communicable Disease Surveillance Centre 2000 to 2005.
Awarded CBE (Commander of the Order of the British Empire) for work after 9/11.
During SARS chaired WHO meetings reviewing epidemiology and control measures. Worked
extensively in China as a visiting consultant for the World Bank on communicable
disease control. From 2005 Seconded National Expert from the UK HPA and as Influenza
Coordinator at ECDC developed and steered its activities on influenza including
its response to avian influenza A(H5N1), its work on pandemic preparedness and seasonal
influenza and with many others ECDC’s response to the 2009 A(H1N1) pandemic in 2009-10.
Joined ECDC properly as a staff member to work leading the Influenza Programme and
on Internal Public Health Training in August 2011.
Dr Kevin Fenton from CDC Atlanta speaks on the subject of
"30 years of HIV/AIDS prevention
in western industrialized settings: what have we learned, where should we be headed?"
Kevin Fenton MD PhD FFPH is the Director of the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention at the Centers for Disease Control and Prevention
in Atlanta, USA. In this role he oversees the agency's prevention research, program
and policy portfolios and activities for the United States and allied global partners.
A public health specialist and infectious disease epidemiologist, Dr Fenton has
worked in the United Kingdom, Europe, and the Caribbean with special focus on surveillance,
behavioral research, health inequities, migration and HIV, and sexual health.
Professor Christian Drosten from the University of Bonn talks on
– highlights from Eurosurveillance"
Christian Drosten graduated in human medicine in 2000 from the University of Frankfurt.
In 2000 he joined the Bernhard Nocht Institute for Tropical Medicine in Hamburg
where he held several posts, most recently as Director of Clinical Virology. His
more important achievements include the identification of the causative agent of
severe acute respiratory syndrome (SARS), in 2003. Drosten has specialised in the
biology and ecology of exotic viruses, including the development of new virus detection
methods. From May 2007, Drosten holds the chair as Professor of Virology at the
University of Bonn. At the same time he assumed the management of the newly founded
Institute for Virology at the Bonn University Hospital.
Pippa Smart, of PSP Consultancy, gives a presentation on
"A publishing revolution fuelled
Pippa Smart is a research consultant working for her own company, PSP Consulting.
She provides training and advice to editors and publishers, specialising in scholarly
journal development and intellectual property rights. She spent almost 20 years
working for commercial and non-profit academic/research publishers including Blackwell
Science, in a variety of roles from production management to business development
and editorial management. She then spent several years working for the development
agency, INASP, supporting editors and publishers in the developing world. She currently
writes the monthly newsletter for the Association of Learned Professional and Scholarly
Publishers (ALPSP), runs her own training course for medical editors in Oxford,
and works around the world with publishers and editors developing their own academic
The opinions expressed by authors contributing to Eurosurveillance
do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance
site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence
. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Eurosurveillance [ISSN] - ©2007-2016. All rights reserved